Home/SEC 13D/G/ELVNSEC 13D/GELVN - Enliven Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified$ELVN$61.28▲ 293.83% YTDHealthcareAug 6, 2026 · ThinkSabio BlogSEC Filing Update: #ELVN Enliven Therapeutics, Inc. : $61.28 Sector: Healthcare | YTD: 🔼+ 293.83% The SEC disclosed Today (06-AUG-2026) that FMR LLC has INCREASED #ELVN Shares by 56.88% 🟢 * Previous Holdings: 6.83M Shares * Current Holdings: 10.71M Shares * Increase+3.88M * Increased(%)+56.88% * Ownership: 15.0% * Estimated Investment Value: $218.03M https://www.thinksabio.com/reports/isr/ELVN The quarterly average prices of #ELVN: Q1 2026: $27.72 Share this post🔗Copy LinkMore filings for $ELVN$ELVN SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 24, 2026$ELVN SEC Filing Update (22-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 22, 2026$ELVN SEC Filing Update (17-JUN-2026) | ThinkSabio - Stocks SimplifiedJun 17, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G